Reducing CoGs & Enhancing Manufacturing Efficiency for Gene Therapies
Time: 11:30 am
day: Focus Day
Details:
• Exploration of methods to lower CoGs through process improvements, automation, and scaling up production capabilities while ensuring consistent product quality for common disease
• Examination of quality measures necessary to support manufacturing scalability, including potency assays, purity testing, and regulatory compliance
• Insights from successful case studies and industry best practices in reducing CoGs and enhancing manufacturing efficiency for gene therapies
